cached image

Evette S. Radisky, Ph.D. - Related publications

Affiliations: 
1995-2000 Chemistry University of Utah, Salt Lake City, UT 
Website:
http://www.mayo.edu/research/faculty/radisky-evette-s-ph-d/bio-00094471
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
10 most relevant papers in past 60 days:
Year Citation  Score
2022 Dey A, Eisenberg S, Birnbaum R, Sharp DJ. 3D-on-2D: A Physiologically Relevant and Gel-Free In Vitro Coculture Method to Assay Antimetastatic Agents. Methods in Molecular Biology (Clifton, N.J.). 2423: 103-107. PMID 34978692 DOI: 10.1007/978-1-0716-1952-0_10   
2022 Salvi A, Young AN, Huntsman AC, Pergande MR, Korkmaz MA, Rathnayake RA, Mize BK, Kinghorn AD, Zhang X, Ratia K, Schirle M, Thomas JR, Brittain SM, Shelton C, Aldrich LN, et al. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer. Cell Death & Disease. 13: 45. PMID 35013112 DOI: 10.1038/s41419-021-04495-w   
2022 Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, Huang Y, Huang J, Pan X. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biology & Therapy. 1-10. PMID 34974792 DOI: 10.1080/15384047.2021.2004835   
2022 Cao W, Shen R, Richard S, Liu Y, Jalalirad M, Cleary MP, D'Assoro AB, Gradilone SA, Yang DQ. Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt. Oncology Reports. 47. PMID 34958116 DOI: 10.3892/or.2021.8252   
2022 Chen P, Hu J, Han X, Chen Y. Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications. Molecular Biology Reports. PMID 35025029 DOI: 10.1007/s11033-022-07126-5   
2022 Yin H, Zhang C, Wei Z, He W, Xu N, Xu Y, Li T, Ren K, Kuang Y, Zhu X, Yuan F, Yu H, Gou X. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation. Cell Death & Disease. 13: 39. PMID 35013128 DOI: 10.1038/s41419-021-04479-w   
2022 Liu XZ, Rulina A, Choi MH, Pedersen L, Lepland J, Takle ST, Madeleine N, Peters SD, Wogsland CE, Grøndal SM, Lorens JB, Goodarzi H, Lønning PE, Knappskog S, Molven A, et al. C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer. Nature Communications. 13: 69. PMID 35013251 DOI: 10.1038/s41467-021-27734-2   
2022 Chen F, Liu J, Song X, DuCote TJ, Byrd AL, Wang C, Brainson CF. EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition. Cancer Letters. 524: 151-160. PMID 34655667 DOI: 10.1016/j.canlet.2021.10.010   
2022 Saha N, Xu K, Zhu Z, Robev D, Kalidindi T, Xu Y, Himanen J, de Stanchina E, Pillarsetty NVK, Dimitrov DS, Nikolov DB. Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells. Translational Oncology. 15: 101265. PMID 34768098 DOI: 10.1016/j.tranon.2021.101265   
2022 Qin D, Ni C, Tan B, Huang S, Deng B, Huang Z. LINC01207 promotes prostate cancer progression by sponging miR-1182 to upregulate AKT3. Oncology Letters. 23: 57. PMID 34992689 DOI: 10.3892/ol.2021.13175